Aldeyra Therapeutics, Inc (NASDAQ: ALDX) had its price target raised by analysts at Citigroup Inc. from $21.00 to $26.00.
Aldeyra Therapeutics, Inc. (ALDX)
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.aldeyra.com/investor-relations
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
ALDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALDX alerts
High impacting Aldeyra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ALDX
News
- Aldeyra Therapeutics, Inc (<a href="https://www.marketbeat.com/stocks/NASDAQ/ALDX/price-target/">NASDAQ: ALDX</a>) had its price target raised by analysts at Oppenheimer Holdings Inc. to $11.00.MarketBeat
- Thinking about buying stock in Bluejay Diagnostics, Sonnet BioTherapeutics, SeaChange International, Rekor Systems, or Aldeyra Therapeutics?PR Newswire
- Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare ConferenceBusiness Wire
- Thinking about buying stock in Aldeyra Therapeutics, Redbox Entertainment, Torrid Holdings, DBV Technologies, or Stealth BioTherapeutics?PR Newswire
- Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 TRANQUILITY-2 Trial in Dry Eye Disease and Intends to Submit New Drug Application for Symptoms and Three Sign Endpoints of Dry Eye DiseaseBusiness Wire
ALDX
Earnings
- 5/5/22 - Beat
ALDX
Sec Filings
- 6/27/22 - Form 4
- 6/27/22 - Form 4
- 6/9/22 - Form 4
- ALDX's page on the SEC website